Cancer
immunotherapy has for the last decade been one of the fastest developing
therapeutic areas in oncology with promising clinical benefits, supporting a
role of immunotherapy as a cornerstone in future cancer treatment
in combination with existing treatments.
Treatment of
early stage cancers today is very efficient due to refined surgery,
chemotherapy, radiation and use of therapeutic antibodies, but a large group of
patients in particular with late stage and metastatic disease have poor
prognosis due to lack of efficient treatment options.
Thus, there is an
urgent need to develop new technologies to provide more efficient treatment of
late stage cancers, focused towards cure of these patients.
No comments:
Post a Comment